文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

低钙血症对脓毒症患者预后的影响

[Influence of hypocalcemia on the prognosis of septic patients].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2019-01-01
一句话结论脓毒症患者低钙血症发生率57.98%,低钙组28天死亡率78.26%显著高于正常血钙组48.00%,血钙水平可作为预后预测指标。

该回顾性研究纳入2017年1月至2018年10月中国科学技术大学附属第一医院重症医学科收治的119例脓毒症患者,按血清钙水平分为正常血钙组(2.00-2.67 mmol/L,50例)和低钙血症组(<2.00 mmol/L,69例),比较两组临床指标及28天预后。低钙血症组APACHE II评分显著高于正常血钙组(25.59±5.52 vs. 22.28±4.89,P<0.01),28天死亡率显著更高[78.26%(54/69)vs. 48.00%(24/50),P<0.01]。死亡组血钙显著低于存活组(1.90±0.20 vs. 2.04±0.19 mmol/L),APACHE II评分显著更高(25.78±5.25 vs. 21.20±4.68)。血钙预测脓毒症预后的AUC为0.70(95%CI 0.602-0.798),最佳截断值1.92 mmol/L,敏感度52.56%,特异度82.93%。

要点

  • 脓毒症患者低钙血症发生率为57.98%(69/119),低钙组28天死亡率78.26%(54/69)显著高于正常血钙组48.00%(24/50)(P<0.01)。
  • 低钙血症组APACHE II评分显著高于正常血钙组(25.59±5.52 vs. 22.28±4.89,P<0.01),两组性别、年龄、CRP、PCT及SOFA评分无显著差异。
  • 死亡组血钙水平显著低于存活组(1.90±0.20 vs. 2.04±0.19 mmol/L),APACHE II评分显著高于存活组(25.78±5.25 vs. 21.20±4.68)(均P<0.01)。
  • 血钙水平预测脓毒症预后AUC为0.70(95%CI 0.602-0.798),最佳截断值1.92 mmol/L,敏感度52.56%,特异度82.93%。
  • 血钙水平与PCT、APACHE II评分呈负相关(r1=-2.10,P1=0.04;r2=-3.91,P2<0.01),与CRP及SOFA评分无相关性。

适用人群与场景

  • 2017年1月至2018年10月中国科学技术大学附属第一医院重症医学科收治的脓毒症患者119例。
  • 按血清钙水平分为正常血钙组(2.00-2.67 mmol/L,50例)和低钙血症组(<2.00 mmol/L,69例)。

诊断标准与关键阈值

  • 低钙血症定义为血清钙<2.00 mmol/L。
  • 正常血清钙定义为血清钙2.00-2.67 mmol/L。
  • 血钙预测脓毒症预后的最佳截断值为1.92 mmol/L。

研究设计与关键结果

  • 研究类型:回顾性分析;样本量119例脓毒症患者;单中心(中国科学技术大学附属第一医院重症医学科)。
  • 低钙血症发生率57.98%(69/119),低钙组血清钙(1.81±0.14)mmol/L,正常血钙组(2.14±0.10)mmol/L。
  • 低钙血症组APACHE II评分显著高于正常血钙组(25.59±5.52 vs. 22.28±4.89,P<0.01),性别、年龄、CRP、PCT及SOFA评分两组无显著差异。
  • 低钙血症组28天死亡率显著高于正常血钙组[78.26%(54/69)vs. 48.00%(24/50),χ2=10.45,P<0.01]。
  • 死亡组血清钙显著低于存活组(1.90±0.20 vs. 2.04±0.19 mmol/L),APACHE II评分显著高于存活组(25.78±5.25 vs. 21.20±4.68),均P<0.01。
  • 血钙水平与PCT、APACHE II评分呈负相关(r1=-2.10,P1=0.04;r2=-3.91,P2<0.01),与CRP及SOFA评分无相关性(r1=0.75,P1=0.46;r2=-1.21,P2=0.23)。
  • ROC曲线分析:血钙预测脓毒症预后的AUC为0.70(95%CI 0.602-0.798),最佳截断值1.92 mmol/L,敏感度52.56%,特异度82.93%。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为低钙血症的脓毒症患者预后较差,血清钙水平可作为脓毒症患者预后的预测指标。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the effect of serum calcium level on the prognosis of patients with sepsis.

METHODS: Clinical data of 119 patients with sepsis admitted to intensive care medicine (ICU) of the First Affiliated Hospital of the University of Science and Technology of China from January 2017 to October 2018 were retrospectively analyzed. Gender, age, and C-reactive protein (CRP), procalcitonin (PCT), serum calcium levels, acute physiology and chronic health evaluation II (APACHE II), sequential organ failure score (SOFA) within 24 hours of diagnosis, and 28-day mortality were collected. The patients were divided into the normal serum calcium group (serum calcium 2.00-2.67 mmol/L) and the hypocalcemia group (serum calcium < 2.00 mmol/L) according to their serum calcium level. The patients were divided into survival group and death group according to 28-day prognosis. Pearson correlation test was used to analyze the correlation between serum calcium level and clinical indicators. Receiver operator characteristic (ROC) curve was used to analyze the predictive value of serum calcium level on prognosis.

RESULTS: A total of 119 patients with sepsis were included, including 50 patients with normal serum calcium, with serum calcium level of (2.14±0.10) mmol/L; and 69 patients of hypocalcemia, and the incidence of hypocalcemia was 57.98%, with serum calcium level of (1.81±0.14) mmol/L. In the hypocalcemia group, except that the APACHE II score was significantly higher than that of the normal serum calcium group (25.59±5.52 vs. 22.28±4.89, P < 0.01), there was no significant difference in gender, age, CRP, PCT and SOFA score between the two groups. The 28-day mortality rate of the hypocalcemia group was significantly higher than that of the normal serum calcium group [78.26% (54/69) vs. 48.00% (24/50), χ2 = 10.45, P < 0.01]. The level of serum calcium in the death group was significantly lower than that in the survival group (mmol/L: 1.90±0.20 vs. 2.04±0.19), while the APACHE II score was significantly higher than the survival group (25.78±5.25 vs. 21.20±4.68), with statistically significant differences (both P < 0.01). There was a negative correlation between serum calcium level and PCT, APACHE II scores in patients with sepsis (r1 = -2.10, P1 = 0.04; r2 = -3.91, P2 < 0.01), but no correlation with CRP and SOFA score (r1 = 0.75, P1 = 0.46; r2 = -1.21, P2 = 0.23). The ROC curve analysis showed that the area under the ROC curve (AUC) for predicting the prognosis of sepsis patients with serum calcium level was 0.70 [95% confidence interval (95%CI) = 0.602-0.798], and the best cut-off value was 1.92 mmol/L, with the sensitivity was 52.56%, and the specificity was 82.93%.

CONCLUSIONS: The prognosis of sepsis patients with hypocalcemia is poor. Serum calcium level can be used as a predictor of prognosis in patients with sepsis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Fei M, Li P, Tao X, et al. [Influence of hypocalcemia on the prognosis of septic patients]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31109413. doi:10.3760/cma.j.issn.2095-4352.2019.04.009

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。